Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF ) Freely available
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (43)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Brigham, S.A.
Right arrow Articles by Farquharson, R.G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brigham, S.A.
Right arrow Articles by Farquharson, R.G.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Reproduction, Vol. 14, No. 11, 2868-2871, November 1999
© 1999 European Society of Human Reproduction and Embryology

A longitudinal study of pregnancy outcome following idiopathic recurrent miscarriage

S.A. Brigham, C. Conlon and R.G. Farquharson1

Department of Obstetrics and Gynaecology, Miscarriage Clinic, Liverpool Women's Hospital, Crown Street, Liverpool L8 7SS, UK

Recurrent miscarriage is a difficult clinical problem occurring in ~1–2% of fertile women. Following investigation, most cases fail to reveal an identifiable cause and are therefore classified as idiopathic. The aim of this study was to identify important gestational milestones for pregnancy success prediction in women following idiopathic recurrent miscarriage. A total of 325 consecutive patients with idiopathic recurrent miscarriage was involved in a prospective longitudinal observational study. Patients were identified from a miscarriage database of 716 patients. Preconceptual presentation and investigation excluded patients from the study sample with known associations of recurrent pregnancy loss, such as antiphosholipid syndrome, oligomenorrhoea, mid-trimester loss and other rare causes, e.g. abnormal parental karyotype. Following early presentation in a subsequent pregnancy, all patients followed a standard clinic protocol including fetal viability ultrasonography on a fortnightly basis throughout the first trimester. Kaplan–Meier curves were constructed for pregnancy outcome. Out of 325 idiopathic cases, 70% (n = 226) conceived, with a 75% success rate. Of 55 miscarriages, longitudinal assessment showed that six losses occurred following detection of fetal cardiac activity (3%). Data from this large study group have enabled accurate prediction of future pregnancy success and have established important gestational milestones for women with idiopathic recurrent miscarriage.

Key words: fetal cardiac activity/idiopathic recurrent miscarriage/pregnancy outcome

1 To whom correspondence should be addressed


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Hum Reprod UpdateHome page
The ESHRE Capri Workshop Group
Genetic aspects of female reproduction
Hum. Reprod. Update, April 2, 2008; (2008) dmn009v1.
[Abstract] [Full Text] [PDF]


Home page
Hum Reprod UpdateHome page
J. Szekeres-Bartho and J. Balasch
Progestagen therapy for recurrent miscarriage
Hum. Reprod. Update, January 1, 2008; 14(1): 27 - 35.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
E. Pasquier, C. Bohec, L. De Saint Martin, C. Le Marechal, M.T. Le Martelot, S. Roche, Y. Laurent, C. Ferec, M. Collet, and D. Mottier
Strong evidence that skewed X-chromosome inactivation is not associated with recurrent pregnancy loss: an incident paired case control study
Hum. Reprod., November 1, 2007; 22(11): 2829 - 2833.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
E. Tuckerman, S.M. Laird, A. Prakash, and T.C. Li
Prognostic value of the measurement of uterine natural killer cells in the endometrium of women with recurrent miscarriage
Hum. Reprod., August 1, 2007; 22(8): 2208 - 2213.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
M.T.M. Franssen, J.C. Korevaar, F. van der Veen, K. Boer, N.J. Leschot, and M. Goddijn
Management of recurrent miscarriage: evaluating the impact of a guideline
Hum. Reprod., May 1, 2007; 22(5): 1298 - 1303.
[Abstract] [Full Text] [PDF]


Home page
Hum Reprod UpdateHome page
P. Donoso, C. Staessen, B.C.J.M. Fauser, and P. Devroey
Current value of preimplantation genetic aneuploidy screening in IVF
Hum. Reprod. Update, January 1, 2007; 13(1): 15 - 25.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
E. Jauniaux, R. G. Farquharson, O. B. Christiansen, N. Exalto, and On behalf of ESHRE Special Interest Group for Earl
Evidence-based guidelines for the investigation and medical treatment of recurrent miscarriage
Hum. Reprod., September 1, 2006; 21(9): 2216 - 2222.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
S. Jivraj, R. Rai, J. Underwood, and L. Regan
Genetic thrombophilic mutations among couples with recurrent miscarriage
Hum. Reprod., May 1, 2006; 21(5): 1161 - 1165.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
R. G. Farquharson, E. Jauniaux, N. Exalto, and on behalf of the ESHRE Special Interest Group for
Updated and revised nomenclature for description of early pregnancy events
Hum. Reprod., November 1, 2005; 20(11): 3008 - 3011.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
A. Weiss, E. Shalev, and S. Romano
Hysteroscopy may be justified after two miscarriages
Hum. Reprod., September 1, 2005; 20(9): 2628 - 2631.
[Abstract] [Full Text] [PDF]


Home page
BMJHome page
F. Kavalier
Investigation of recurrent miscarriages
BMJ, July 16, 2005; 331(7509): 121 - 122.
[Full Text] [PDF]


Home page
Hum ReprodHome page
A.R. Thornhill, C.E. deDie-Smulders, J.P. Geraedts, J.C. Harper, G.L. Harton, S.A. Lavery, C. Moutou, M.D. Robinson, A.G. Schmutzler, P.N. Scriven, et al.
ESHRE PGD Consortium 'Best practice guidelines for clinical preimplantation genetic diagnosis (PGD) and preimplantation genetic screening (PGS)'
Hum. Reprod., January 1, 2005; 20(1): 35 - 48.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
C. Kruse, K. Varming, and O.B. Christiansen
Prospective, serial investigations of in-vitro lymphocyte cytokine production, CD62L expression and proliferative response to microbial antigens in women with recurrent miscarriage
Hum. Reprod., November 1, 2003; 18(11): 2465 - 2472.
[Abstract] [Full Text] [PDF]


Home page
Obstet GynecolHome page
R. Rai, L. Regan, W. H. Kutteh, R. G. Farquharson, S. M. Quenby, and M. Greaves
Antiphospholipid Syndrome in Pregnancy: A Randomized, Controlled Trial of Treatment
Obstet. Gynecol., December 1, 2002; 100(6): 1354 - 1356.
[Full Text] [PDF]


Home page
Obstet GynecolHome page
R. G. Farquharson, S. Quenby, and M. Greaves
Antiphospholipid Syndrome in Pregnancy: A Randomized, Controlled Trial of Treatment
Obstet. Gynecol., September 1, 2002; 100(3): 408 - 413.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
L. Bricker and R.G. Farquharson
Types of pregnancy loss in recurrent miscarriage: implications for research and clinical practice
Hum. Reprod., May 1, 2002; 17(5): 1345 - 1350.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
S.M. Laird, N.D. Quinton, B. Anstie, T.C. Li, and A.I.F. Blakemore
Leptin and leptin-binding activity in women with recurrent miscarriage: correlation with pregnancy outcome
Hum. Reprod., September 1, 2001; 16(9): 2008 - 2013.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.